Viatris brings to completion all previously announced divestitures with the closing of its over-the-counter business divestiture

Achievement of this major milestone further simplifies and strengthens the company and positions viatris to achieve its key priorities and accelerate future growth pittsburgh , july 3, 2024 /prnewswire/ -- viatris inc. (nasdaq: vtrs), a global healthcare company, today announced that it has closed the divestiture of its over-the-counter (otc) business to cooper consumer health, a leading european over-the-counter drug manufacturer and distributor, bringing to substantial completion all previously announced divestitures. in october, the company announced it had entered into agreements to divest substantially all of its otc business, as well as its women's healthcare business, its active pharmaceutical ingredients (api) business in india and commercialization rights in certain non-core markets.
VTRS Ratings Summary
VTRS Quant Ranking